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Abstract Öz 
The term “hemophagocytosis” describes the pathologic 
finding of activated macrophages, engulfing erythrocytes, 
leukocytes, platelets and their precursor cells. This 
phenomenon is an important finding in patients with 
hemophagocytic syndrome. It is a distinct clinical entity 
characterized by fever, pancytopenia, splenomegaly and 
hemophagocytosis in bone marrow, liver and lymph 
nodes. Hemophagocytic syndrome can be classified 
according to the underlying etiology into either primary 
(genetic) or secondary (acquired). Severe infections, 
malignancies, rheumatologic disorders and some metabolic 
diseases can lead to secondary hemophagocytic syndrome. 
Infection-associated hemophagocytic syndrome 
implicating Leishmania is very rare and often difficult to 
diagnose. Therefore, we aimed to report a young boy with 
Visceral Leishmaniasis associated hemophagocytic 
syndrome. 
Hemofagositoz terimi, aktive makrofajlari, fagosite edilmiş 
eritrosit, lökosit, trombosit ve onların öncül hücrelerini 
tarif etmektedir. Bu fenomen, hemofagositik sendromun 
önemli bir bulgusudur. Hemofagositik sendrom, ateş, 
pansitopeni, splenomegali ve kemik iliği, karaciğer ile lenf 
nodunda hemofagositoz ile karakterizedir. Hemofagositik 
sendrom, altta yatan etyolojiye göre primer (genetik) ve 
sekonder (kazanılmış) olmak üzere sınıflandırılabilir. Ağır 
enfeksiyonlar, kanserler, romatolojik hastalıklar ve bazı 
metabolik hastalıklar sekonder hemofagositik sendroma 
neden olabilmektedir. Leishmania’ nın neden olduğu 
enfeksiyon ilişkili hemofagositik sendrom çok nadirdir ve 
sıklıkla tanıda zorluklara yol açmaktadır. Bundan dolayı 
Visseral Leishmaniazis ilişkili hemofagotik sendromlu genç 
bir hasta sunulması amaçlanmıştır. 
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INTRODUCTION 
The term “hemophagocytosis” describes the 
pathologic finding of activated macrophages, 
engulfing erythrocytes, leukocytes, platelets, and 
their precursor cells1. This phenomenon is an 
important finding in patients with hemophagocytic 
syndrome, more properly referred to as 
hemophagocytic lymphohistiocytosis (HLH)1. 
Hemophagocytic syndrome is a potentially fatal 
hyperinflammatory condition caused by a highly 
stimulated but ineffective immune response2. It is a 
distinct clinical entity characterized by fever, 
pancytopenia, splenomegaly and hemophagocytosis 
in bone marrow, liver and lymph nodes1. The 
incidence is estimated to be approximately 1.2 cases 
per million individuals per year, but this is almost 
certainly an underestimate2. Broadly, 
hemophagocytic syndrome can be classified 
according to the underlying etiology into either 
primary (genetic) or secondary (acquired)2. Since the 
first description of perforin gene mutations by Stepp 
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et al in 1999, significant insight has been gained into 
the genetic mutations that give rise to the 
hemophagocytic syndrome phenotype2. Specific 
diagnostic criteria were used for patient eligibility in 
the Histiocyte Society (HS) trials HLH-94 and 
HLH-20042. The diagnosis of HLH can be 
established if one of either 1 or 2 below is fulfilled;  
1. A molecular diagnosis consistent with HLH is 
made. 
2. Diagnostic criteria for HLH are fulfilled (5 of 
the 8 criteria below): 
1. Fever 
2. Splenomegaly 
3. Cytopenias (affecting >2-3 lineages in the 
peripheral blood): 
a. Hemoglobin <90 g/L (in infants <4 
weeks of ages, hemoglobin <100 g/L) 
b. Platelets <100 x 109/L 
c. Neutrophils <1.0 x 109/L 
4. Hypertriglyceridemia and / or  
hypofibrinogemia :  
a. Fasting triglycerides ≥3.0 mmol/L (ie, 
265mg/dL) 
b. Fibrinogen ≤1.5 g/L 
5. Hemophagocytosis in bone marrow, 
spleen, or lymph nodes 
6. Low or absent NK-cell activity (according 
to local laboratory reference) 
7. Ferritin ≥500 µg/L 
8. Soluble CD25 (ie, sIL2r) ≥2400 U/mL 
(Supportive criteria include neurologic symptoms, 
cerebrospinal fluid pleocytosis, conjugated 
hyperbilirubinemia and transaminitis, 
hypoalbuminemia, hyponatremia, elevated D-dimers 
and lactate dehydrogenase. The absence of 
hemophagocytosis in the bone marrow does not 
exclude a diagnosis of HLH)2. 
Hemophagocytic syndrome may also occur as a 
secondary disorder in association with severe 
infections, malignancies, rheumatologic disorders 
and some metabolic diseases2. Hemophagocytic 
syndrome has since been associated with a variety of 
viral, bacterial, fungal, and parasitic infections1. 
Ebstein-Barr virus (EBV) is the most common 
cause of infection-associated hemophagocytic 
syndrome2. Infection associated hemophagocytic 
syndrome implicating Leishmania is very rare and 
often difficult to diagnose3. Therefore, we aimed to 
report a young boy with visceral leishmaniasis 
associated hemophagocytic syndrome. 
CASE 
A previously healthy 20 year-old boy presented with 
fever (>38˚C) lasting for 3 days. The patient was 
detected to smoke and use alcohol. On admission, 
physical examination revealed heart rate 102 bpm, 
blood pressure 100/60 mmHg, body temperature 39 
˚C, pallor, hepatosplenomegaly. Hemoglobin level 
9.4 (13.5-18.0) gr/dl, white blood cell count 1.29 
(4.0-11.5) x103 /µL and platelet count 37.8 (130-
400) x103 /µL, fibrinogen level 0.77 (1.8-3.5) g/L, 
serum albumin 2.6 (3.2-5.0) g/dL were decreased, 
and erythrocyte sedimentation rate 49 (0-20) 
mm/hour, C-reactive protein level 123 (0-6.0) 
mg/L, prothrombin time (PT) 16.5 (11.0-15.0) sec, 
activated thromboplastin time (aPTT) 52.7 (22.1-
36.0) sec, D-dimer 5468 (0-500.0) µg/L, aspartate 
aminotransferase (AST) 348 (7-40) IU/L, alanin 
aminotransferase (ALT) 152 (5-35) IU/L, lactate 
dehydrogenase (LDH) 933 (105-235) IU/L and 
serum ferritn level >2000 (22-322) ng/mL were all 
elevated.  
Pericardial and bilateral pleural effusion, massive 
hepatosplenomegaly, ascites, paraaortic lymph nodes 
were detected on computed tomography scan. Bone 
marrow examination revealed erythroid hyperplasia, 
elevated plasma cells and histiocytes, and 
erythroblasts phagocyted histiocytes (Figure 1), but 
no etiological factor for hemophagocytic syndrome 
was detected.  
 
Figure 1. Bone marrow cells were engulfed by 
histiocyte cell of bone marrow. 
General condition and laboratory findings of the 
patient deteriorated gradually within two weeks. 
Amastigotes of Leishmania was detected in the 
second bone marrow examination, (Figure 2). 
Antibody scanning with immunofluoresence test 
and rK39 immunochromatic dipstick testing for 
Leishmania were positive. The symptoms and 
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laboratory findings of the patient improved 
gradually within days after administration of 
liposomal amphotericin B. 
 
Figure 2. Amastigotes of Leishmania were engulfed 
by histiocyte cell in bone marrow. 
DISCUSSION 
Hemophagocytic lymphohistiocytosis is a disorder 
characterized by nonmalignant infiltration of vital 
organs by activated lymphocytes and macrophages4. 
Engulfment of any hematological cell type in bone 
marrow and reticuloendothelial system by these 
activated cells, called hemophagocytosis is the hall 
mark of the disease4. This may result in 
pancytopenia, fever, organ enlargement, 
neurological dysfunction and disseminated 
intravascular coagulation4. 
Visceral Leishmaniasis is a generalized protozoan 
infection of the reticuloendothelial system caused by 
the genus Leishmania and transmitted by a bite from 
the infected sand fly, Phlebotomus5. The disease is 
endemic in the Middle East, East Africa and 
Southern Europe5. Visceral Leishmaniasis is 
characterized by fever, hepatosplenomegaly, 
lymphadenopathy and various hematological 
abnormalities5. The most common hematologic 
manifestation of Visceral Leishmaniasis is anemia, 
however the patient may develop leukopenia, 
thrombocytopenia, pancytopenia, coagulation 
abnormalities and hemophagocytic syndrome5-7. 
Hemophagocytic syndrome is a rare life-threatening 
complication of Visceral Leishmaniasis6.  
As discussed above, Visceral Leishmaniasis may 
mimic or lead to several types of hematological 
disorders including hemophagocytic syndrome3. 
Diagnostic delay might cause severe complications 
and death occurs in 90% of the patients without 
specific anti-Leishmanial treatment4. In our patient, 
we detected no etiological factors for 
hemophagocytic syndrome in the first bone marrow 
examination because of low parasitic load, so two 
weeks of time was lost. However we were able to 
detect Leishmania parasites in the second bone 
marrow examination. 
In conclusion, the findings and symptoms of 
Visceral Leishmaniasis and hemophagocytic 
syndrome are very similar and also overlap. The 
early diagnosis and treatment of Visceral 
Leishmaniasis-related hemophagocytic syndrome is 
vital. Therefore, Visceral Leishmaniasis should be 
screened when hemophagocytic syndrome is 
detected in any patient. 
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